JP2016508143A5 - - Google Patents

Download PDF

Info

Publication number
JP2016508143A5
JP2016508143A5 JP2015551157A JP2015551157A JP2016508143A5 JP 2016508143 A5 JP2016508143 A5 JP 2016508143A5 JP 2015551157 A JP2015551157 A JP 2015551157A JP 2015551157 A JP2015551157 A JP 2015551157A JP 2016508143 A5 JP2016508143 A5 JP 2016508143A5
Authority
JP
Japan
Prior art keywords
fusion protein
polypeptide
amino acid
seq
pharmaceutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015551157A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016508143A (ja
Filing date
Publication date
Priority claimed from EP13150171.0A external-priority patent/EP2752426A1/en
Application filed filed Critical
Publication of JP2016508143A publication Critical patent/JP2016508143A/ja
Publication of JP2016508143A5 publication Critical patent/JP2016508143A5/ja
Pending legal-status Critical Current

Links

JP2015551157A 2013-01-03 2013-12-18 ヒト血清アルブミン結合化合物およびその融合タンパク質 Pending JP2016508143A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13150171.0 2013-01-03
EP13150171.0A EP2752426A1 (en) 2013-01-03 2013-01-03 Human serum albumin binding compounds and fusion proteins thereof
PCT/EP2013/077227 WO2014106583A1 (en) 2013-01-03 2013-12-18 Human serum albumin binding compounds and fusion proteins thereof

Publications (2)

Publication Number Publication Date
JP2016508143A JP2016508143A (ja) 2016-03-17
JP2016508143A5 true JP2016508143A5 (enExample) 2017-01-12

Family

ID=47458817

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015551157A Pending JP2016508143A (ja) 2013-01-03 2013-12-18 ヒト血清アルブミン結合化合物およびその融合タンパク質

Country Status (7)

Country Link
US (2) US9790475B2 (enExample)
EP (2) EP2752426A1 (enExample)
JP (1) JP2016508143A (enExample)
AU (1) AU2013372004B2 (enExample)
CA (1) CA2896962A1 (enExample)
HK (1) HK1215441A1 (enExample)
WO (1) WO2014106583A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160060660A (ko) 2013-10-01 2016-05-30 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 친화성 크로마토그래피를 위한 및 치료제의 반감기를 연장시키기 위한 화합물
US20200087390A1 (en) 2016-12-21 2020-03-19 Amgen Inc. Anti-tnf alpha antibody formulations
AU2018220516B2 (en) 2017-02-16 2025-03-06 Sonnet BioTherapeutics, Inc. Albumin binding domain fusion proteins
CN107353346A (zh) * 2017-08-09 2017-11-17 芜湖英特菲尔生物制品产业研究院有限公司 一种由猪白蛋白与猪干扰素γ组成的融合蛋白及其制备方法和一种重组猪长效干扰素γ
JP2022521428A (ja) 2019-02-25 2022-04-07 ザ・ユニバーシティ・オブ・シカゴ 抗炎症剤に連結されたecm親和性ペプチドを用いて炎症性状態および自己免疫状態を処置するための方法および組成物
US20230190881A1 (en) 2020-02-17 2023-06-22 Biotest Ag Subcutaneous administration of factor viii
CN115698063A (zh) * 2020-03-06 2023-02-03 匹兹堡大学联邦高等教育系统 血清白蛋白结合纳米抗体组合物以及其使用方法
CN114075279B (zh) * 2020-08-14 2023-05-05 上海洛启生物医药技术有限公司 非pH依赖性长效型抗血清白蛋白纳米抗体及其应用
US12134635B1 (en) 2023-12-29 2024-11-05 Sonnet BioTherapeutics, Inc. Interleukin 18 (IL-18) variants and fusion proteins comprising same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
SE509359C2 (sv) 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
US6080560A (en) 1994-07-25 2000-06-27 Monsanto Company Method for producing antibodies in plant cells
DE60030323T2 (de) 1999-12-24 2007-10-11 Genentech, Inc., South San Francisco Verfahren und verbindungen zur verlängerung der halbwertzeiten bei der ausscheidung von biowirksamen verbindungen
WO2002076489A1 (en) 2001-03-09 2002-10-03 Dyax Corp. Serum albumin binding moieties
NZ540194A (en) 2002-11-08 2008-07-31 Ablynx Nv Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
EP1892248A1 (en) * 2006-08-21 2008-02-27 Eidgenössische Technische Hochschule Zürich Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase
EP2524927A1 (en) * 2011-05-20 2012-11-21 Covagen AG New chymase binding compounds and medical uses thereof
AU2013231488B2 (en) * 2012-03-16 2017-12-07 Covagen Ag Novel binding molecules with antitumoral activity

Similar Documents

Publication Publication Date Title
JP2016508143A5 (enExample)
JP2015212284A5 (enExample)
US10774157B2 (en) Multispecific antibodies
JP2015509707A5 (enExample)
JP2022046510A (ja) 血清アルブミン結合フィブロネクチンiii型ドメイン
JP2016053091A5 (enExample)
RU2012149858A (ru) Получение гетеромультимерных белков
JP2018515096A5 (enExample)
US20180334513A1 (en) Multispecific antibodies
JP2013517783A5 (enExample)
JP2015525217A5 (enExample)
JP2014526881A5 (enExample)
JP2016519933A5 (enExample)
JP2014528696A5 (enExample)
JP2016000731A5 (enExample)
JP2012095652A5 (enExample)
JP2014503198A5 (enExample)
HRP20130194T1 (hr) Imunosupresivni polipeptidi i nukleinske kiseline
JP2010068806A5 (enExample)
JP2017514522A5 (enExample)
JP2005523681A5 (enExample)
CN106188286A (zh) 一种中和埃博拉病毒的纳米抗体
JP2010538619A5 (enExample)
JP2013529178A5 (enExample)
JP2014505014A5 (enExample)